Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: favourite (50), preference (97)

Echogenic lung lesion - patient information

Description: This factsheet explains what an echogenic lung lesion (ELL) is, the possible causes and what this means for you and your
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Echogenic-lung-lesion-3592-PIL.pdf

Patient-initiated follow-up (PIFU) for CLL, SLL, LMZL and HCL - patient information

Description: This booklet contains a summary of patient-initiated follow-up (PIFU) for chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), leukaemic
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Patient-initiated-follow-up-PIFU-for-CLL-SLL-LMZL-and-HCL-3322-PIL.pdf

WRES report and action plan 2023

Description: Workforce Race Equality Standard Annual Report 2023 1 Table of Contents Executive Summary.............................................
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/WRES-report-and-action-plan-2023.pdf

Making your advance care plan (BMT and cellular therapy) - patient information

Description: This booklet is about how to make an advance care plan. An advance care plan is a record of your thoughts
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Making-your-advance-care-plan-BMT-and-cellular-therapy-3623-PIL.pdf

Familial adenomatous polyposis (FAP) - patient information

Description: This booklet is for people attending the clinical genetics service with a personal or family history of familial adenomatous polyposis (FAP
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Familial-adenomatous-polyposis-FAP-1429-PIL.pdf

Differences in sex development (DSD) clinic - patient information

Description: This factsheet explains what the differences in sex development (DSD) clinic is, why your child has been referred t
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Differences-in-sex-development-DSD-clinic-3504-PIL.pdf

Papers Trust Board 27 May 2021

Description: Date Time Location Chair Agenda Trust Board – Open Session 27/05/2021 9:00 - 13:00 Microsoft Teams Peter Hollins 1 Chair’
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2021-Trust-document/TB-papers/Papers-Trust-Board-27-May-2021.pdf

Carboplatin(AUC6)-Pemetrexed

Description: Chemotherapy Protocol MESOTHELIOMA CARBOPLATIN (AUC6)-PEMETREXED Regimen • Mesothelioma – Carboplatin (AUC6)-Pemetrexed Indication • First line therapy of advanced pleural mesothelioma where the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/CarboplatinAUC6-Pemetrexed-Ver1.5.pdf

Carboplatin and Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-PEMETREXED Regimen • NSCLC – Carboplatin-Pemetrexed Indication • First line therapy of stage IIIB
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pemetrexed-Ver1.4.pdf

Carboplatin (AUC4)-Gemcitabine (day 1, 8) Retreat

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1, 8) Retreat Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday18Retreat.pdf

241 to 250 of 404

Previous … 23 24 25 26 27 … Next